Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-30

Clinical Trial Update: A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems [Phase 1]

View source ↗

Summary

A Phase 1 study assessing how iclepertin is absorbed and distributed in people with renal insufficiency compared to those with normal kidney function; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iclepertin

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2026-03-30